Streetbeat News

Stock Prices

WVE

Wave Life Sciences Ltd (NASDAQ:WVE) announced positive results from its Phase 1b/2a SELECT-HD trial of WVE-003 for Huntington’s disease. The trial showed significant lowering of mutant huntingtin protein and preservation of healthy huntingtin protein, with no serious adverse events reported. Despite the positive results, WVE shares traded down 3.07% to $5.05.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 1:37 pm

IXN

MSFT

TEAM

XLK

The European Union has charged Microsoft with anti-competitive practices for bundling its Teams app with its Office suite, potentially disadvantaging competitors like Slack and Zoom. Microsoft is attempting to address these concerns by proposing to unbundle Teams from Office products outside Europe. The company faces a potential fine of up to 10% of its annual global revenues if found guilty. Microsoft is also under scrutiny for its $13 billion partnership with OpenAI. Over the last decade, Microsoft has paid $1.71 billion in EU antitrust fines. Microsoft stock has gained over 36% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

June 25, 2024 | 1:36 pm

GRAL

ILMN

Cancer test maker Grail has started trading at $18.35 per share after being spun off from Illumina.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:33 pm

FBLG

FibroBiologics has announced preliminary proof-of-concept results for its novel artificial thymus organoid technology, which could have significant implications for regenerative medicine and immune system therapies.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:32 pm

OGEN

Oragenics Inc (NASDAQ:OGEN) shares fell by 21% to $1.03 after the company announced a proposed public offering of 1.1 million shares at $1.00 per share, expected to close around June 26. The offering aims to generate approximately $1.1 million to support the development of their ONP-002 product and general corporate purposes.

Portfolio Pulse from Henry Khederian

June 25, 2024 | 1:26 pm

NVDA

RXRX

Recursion Pharmaceuticals (NASDAQ: RXRX) shares are trading higher after CEO Chris Gibson's CNBC interview and upcoming presentation with Nvidia's Jensen Huang. The discussion focused on AI's role in drug discovery, highlighting Recursion's BioHive-2 supercomputer built with Nvidia's help. Needham analyst Gil Blum reiterated a Buy rating for RXRX with a $17 price target.

Portfolio Pulse from Adam Eckert

June 25, 2024 | 1:23 pm

ARM

AVGO

DELL

NVDA

QCOM

SMCI

Nvidia Corp (NASDAQ:NVDA) experienced a significant stock price drop after briefly becoming the world's most valuable company. This decline also impacted other tech companies linked to the AI boom, including Super Micro Computer Inc (NASDAQ:SMCI), Dell Technologies Inc (NYSE:DELL), Arm Holdings Plc (NASDAQ:ARM), Qualcomm Inc (NASDAQ:QCOM), and Broadcom Inc (NASDAQ:AVGO). Despite the drop, experts believe Nvidia's performance will continue to be strong for the next 18-24 months, making it a good time to buy the dip. Geopolitical tensions between the U.S. and China could negatively affect semiconductor stocks.

Portfolio Pulse from Anusuya Lahiri

June 25, 2024 | 1:22 pm

SEDG

SolarEdge Technologies Inc (NASDAQ:SEDG) shares are trading lower after the company announced a private offering of $300 million convertible senior notes due 2029. The offering is targeted at qualified institutional buyers, with an option to purchase an additional $45 million. The proceeds will be used for capped call transactions.

Portfolio Pulse from Adam Eckert

June 25, 2024 | 1:22 pm

MMAT

The SEC has charged Meta Materials (MMAT) and its former CEOs with market manipulation, fraud, and other violations. This legal action could have significant implications for the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:20 pm

Toyota Motor Corp. (NYSE: TM) Chairman Akio Toyoda received a pay raise to $10.2 million for fiscal year 2023, despite governance and safety concerns. This comes amid a government safety probe and reduced shareholder support. Toyota reported record operating income and maintained its position as the world's top vehicle manufacturer.

Portfolio Pulse from Benzinga Neuro

June 25, 2024 | 1:20 pm